coming soon
Sutter Health Research Enterprise
2800 L Street
Suite 300
Sacramento, CA, 95816
(916) 453-3300
nagij1@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Napoli 3-Ipsen (D-US-60010-001)
Randomized, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin,
5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Brian K. Kim M.D, Jasdeepa Nagi M.D., Sivakumar Reddy M.D.
Status: Active, Recruiting
RESILIENT-Ipsen (MM-398-01-03-04)
A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection vs Toptecan
in patients with SCLC
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Rajeswari Chellappah M.D., Brian K. Kim M.D, Jasdeepa Nagi M.D., Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.
Status: Active, Not Recruiting